Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2017 Jun 1.
Published in final edited form as: Nutr Clin Pract. 2016 Mar 18;31(3):342–348. doi: 10.1177/0884533616629636

REGIONAL COMPARISON OF ENTERAL NUTRITION-RELATED ADMISSION POLICIES IN SKILLED NURSING FACILITIES

Marissa Burgermaster a, Eoin Slattery c, Nafeesa Islam d, Paul R Ippolito e, David S Seres a,b,*
PMCID: PMC4875841  NIHMSID: NIHMS747463  PMID: 26993318

Abstract

Background

Nursing home admission policies are one driver of increased and earlier gastrostomy placement, a procedure that is not always medically or ethically indicated among patients needing short-term nutrition support. This important clinical decision should be based upon patient prognosis, goals, and needs. We compared nursing home enteral nutrition-related admission policies in New York City and other regions of the United States. We also explored motivations for these policies.

Methods

We conducted a telephone survey with skilled nursing facility administrators in New York City and a random sample of facilities throughout the United States about enteral nutrition-related admission policies. Survey data were matched with publically available Centers for Medicare and Medicaid Services facility characteristics data. The relationship between facility location and admission policies was described with regression models. Reasons for these policies were thematically analyzed.

Results

New York City nursing homes were significantly less likely to admit patients with nasogastric feeding tubes than nursing homes nationwide, controlling for facility characteristics (OR=0.111, 95% CI=0.032, 0.344). Reasons for refusing nasogastric tubes fell into five categories: Safety, capacity, policy, perception of appropriate level of care, and patient quality of life.

Conclusion

Our findings indicate that enteral nutrition-related admission policies vary greatly between nursing homes in New York City and nationwide. Many administrators cited safety and policy as factors guiding their institutional policies and practices, despite a lack of evidence. This gap in research, practice, and policy has implications for quality and cost of care, length of hospital stay, and patient morbidity and mortality.

Keywords: Enteral Nutrition, Nursing Homes/Organization and Administration, Medical Ethics, Nasogastric Feeding, Percutaneous Endoscopic Gastrostomy

Background

Nutrition support is a life-saving therapy for many patients requiring post-acute and long-term care (LTC). As of 2010, about 6% of the 1.6 million people living in skilled nursing facilities (SNFs) were receiving enteral nutrition (EN – tube feeding)1, with much higher rates reported for those with cognitive impairment2,3.

Whether and how EN is provided is an important clinical decision that should be based upon diagnosis, comorbidities, risk factors, and prognosis as well as patient goals and needs1,4,5,6,7,8,9,10. Decision-making should be based on patient preference when research does not indicate superiority of one or the other access methods.

Feeding with small bore nasogastric feeding tubes (NGFT), is safe and appropriate for short- to medium-term EN (i.e., <30-90 days)7. A feeding gastrostomy (FG) is considered appropriate for longer term feeding.

Feeding gastrostomies are relatively contraindicated in advanced cognitive disorders, such as dementia11,12. An increased risk of complications related to FGs has been demonstrated in patients with cirrhosis13; non-head/neck or thoracic malignancy14; pneumonia12,15; esophageal obstruction16; and diabetes16,17,18. Nor do gastrostomies prevent pneumonia12,15. Patients who are older and those who are male19 as well as those with ascites13, sepsis16, peritonitis18, active coagulopathy16, organ failure19, or low serum albumin17 have also been demonstrated to be at increased risk when undergoing FG.

Results of systematic comparisons of NGFT and FG feeding are inconsistent; further, they are based on a small number of low and moderate quality trials20. A recent review of observational and randomized studies among non-stroke dysphagia patients found that NGFT feeding was not associated with pneumonia or overall complications when compared with FG21. A Cochrane review found that NGFT feeding was not associated with increased mortality when compared with FG, though FG was associated with significantly less intervention failure, defined as feeding interruption, blockage, or non-adherence20. Nasal bridles have been demonstrated to be a safe way to improve NGFT reliability by reducing dislodgement and therefore feeding interruption22,23,24; however, they are infrequently used23. In a prospective descriptive analysis of 140 nasal bridle placements in a UK hospital, patients were fed via bridled NGFT for a median 7 days, with 52% regaining adequate swallow within 28 days, and reported no complications23. It should be noted that the long-term use in SNFs has not been well studied.

It has been suggested that FG is overused from an ethical standpoint25,26,27. In one UK hospital, FG use and 30-day mortality increased 10-fold and 3-fold, respectively, from 1992-200228. FG insertion is not a frivolous procedure: it is often painful29, complication rates are reported variably between 13-40% 30, and 30-day mortality is reported variably between 10 and 26%19, 31. FG futility rates (i.e., patients die in hospital within days of insertion) have been measured as high as 19%32 and an evaluation of survivors in one series found that 73% had FGs removed, and after relatively short use (median=76 days)33. Delaying FG placement until 30-days after discharge has been associated with 40% lower 30-day post procedure mortality (p=.01)34. Further, a recently published observational cohort study demonstrated that FG placement can be safely and effectively done in the outpatient setting35. These findings suggest FG insertion may be avoided in a large number of patients.

This evidence also suggests that temporary, non-surgical NGFT feeding may be the best care for many patients who are being discharged from hospitals to SNFs, particularly when prognosis for return to self-feeding is short or unknown. Both hospitals and SNFs should be equipped to care for patients with different EN access based on collaborative decisions made by patients, their families, and their medical teams. Despite this, a move towards earlier insertion of FGs has become commonplace33. Further, some have attributed this trend to nursing home admission policies3,19; SNF characteristics, including staffing36; and “reasons of administrative and professional convenience”26. Regional differences in enteral nutrition practices have also been identified3,37,38.

If patients receiving NGFT are systematically denied admission to SNFs in certain regions, the rate of FG may be unnecessarily high, as may be the potential for FGs placed outside of medical and ethical indications. In addition to patient mortality and quality of life concerns, the refusal of SNFs to accept patients receiving NGFT feeding could exert significant financial pressure on hospitals by prolonging length of stay for FG insertion prior to discharge and for the cost of the procedure itself. In order to improve EN practices and outcomes in hospitals and LTC, it is important to better understand SNF EN admission policies.

In the current study we sought to: 1) quantify SNF EN admission policies in a large city on the east coast of the United States (US), 2) assess regional disparity in admission policies by comparing these SNFs to a random sample of SNFs throughout the US, and 3) Describe SNF administrators’ perceptions about their facilities’ reasoning for their EN admission policies.

Methods

We performed a mixed methods, cross-sectional study and followed an explanatory sequential design39 that used participants’ responses to an open-ended survey question to provide a more in-depth explanation of the results of a quantitative analysis of the same survey data.

Participants

We contacted administrators at every SNF in the five boroughs of New York City (NYC; n=126), and a randomly selected comparison cohort from the entire US (n=100) between June and November 2013. Nursing directors, admission directors, and directors of social work at selected SNFs were eligible to participate. Appropriate sample size for 95% power at α=.05 to detect a difference in admission policy (i.e., accept/reject NGFT) was calculated, and a random sample of SNFs across the US was selected from the publicly available Centers for Medicare and Medicaid Services (CMS) database40. Nationwide SNFs were oversampled by two-fold to account for potential non-response. A total of 222 facilities were contacted. No facilities were excluded from the NYC sample; 5 facilities were excluded from the nationwide sample: 2 were in NYC, 3 were not SNFs. Participating SNF administrators provided verbal informed consent prior to beginning the phone survey. The Columbia University Medical Center Institutional Review Board (IRB) approved the study protocol.

Survey

A trained research assistant (RA) contacted SNF administrators at each SNF by phone and invited them to participate in a brief verbal survey. Each SNF was contacted up to five times until contact with the appropriate administrator was made. Once it was determined that an administrator was eligible to participate, the RA used a scripted protocol to conduct the survey, first asking if the facility had an explicit policy regarding admission of patients with NGFTs. The RA then asked the administrator to confirm if their SNF admits patients with NGFTs. Follow up questions queried the formality (i.e., is this common practice or a written policy?) and origin (i.e., is your policy or practice based on a policy from a regulatory or government agency?) of the institutional policy. Administrators who did not report basing their policy on specific government or agency policies were asked to comment on the basis of their EN policy. Balancing feasibility and precision, the RA took extensive notes during the phone survey, including verbatim quotes when possible. Responses to the question about NGFT acceptance were coded yes or no. The reasons for NGFT acceptance or non-acceptance were descriptively coded and quantified. When there were questions about coding, two or more members of the research team examined the data and reached consensus.

Secondary Data

Data about SNF characteristics, including staffing levels, facility size, type of ownership, CMS rating scores, health and quality of care deficiencies, and fines were obtained from the CMS website for the SNFs in the selected sample and were matched with survey data40.

Analyses

Data for SNFs with both survey responses and CMS-reported characteristics were used for descriptives and logistic regressions (USA n=71, NYC n=92). Means and frequencies for SNF characteristics were calculated in order to describe the study sample. T-tests were used to identify significant differences in characteristics between NYC and nationwide samples. Two logistic regression models were used to determine the relationship between location and NGFT acceptance. In the naïve model, the binary location, (i.e., NYC or nationwide) was regressed on NGFT acceptance. The second model controlled for various SNF characteristics. All statistical analyses were conducted in R version 3.1.1(R Core Team, 2013).

All survey data were used for the qualitative analysis (USA=72, NYC=107). Frequencies and percentages for each NGFT feeding non-acceptance descriptive code were calculated by sample, descriptive codes were categorized by theme, and exemplar quotes from the NYC and nationwide samples were selected.

Results

Survey response rate was 81.4% (USA=75.7%, NYC=84.9%) with total contact rate of 83.7%, and a total cooperation rate of 97.3% (221 telephone numbers, 180 completed interviews, 5 refusals, 36 non-contact). Only 18.3% of NYC SNFs (n=17) reported accepting patients with NGFTs, whereas 62% of SNFs nationwide (n=44) reported accepting patients with NGFT. We were able to match 73% of SNFs in our sample with data on SNF characteristics from CMS. For-profit corporations owned most SNFs in both samples. All SNF characteristics, except substandard quality of care deficiencies, were significantly different between the two samples. Descriptive statistics for nationwide and NYC SNFs are reported in Table 1.

Table 1.

CMS-Reported Characteristics of Nursing Homes Surveyed across the United States (US) and in New York City (NYC)

US (n=71) NYC (n=93)
Characteristic n % n %
NGFT acceptance 44 62*** 17 18.3***
Ownership Type
For profit - Corporation 42 59.2 41 44.1
For profit - Individual 2 2.8 10 10.8
For profit - Limited Liability 0 0 2 2.2
For profit - Partnership 2 2.8 10 10.8
Government - City 1 1.4 1 1.1
Government - City/County 0 0 1 1.1
Government - County 5 7 0 0
Government - Federal 0 0 1 1.1
Government - State 1 1.4 0 0
Non profit - Church related 4 5.6 4 4.3
Non profit - Corporation 14 19.7 22 23.7
Non-profit- other 0 0 1 1.1
Mean SD Mean SD
CNA hrs/pt/dayŧ 2.5** 0.5 2.3** 0.5
LPN hrs/pt/dayŧ 1*** 0.4 0.7*** 0.3
RN hrs/pt/dayŧ 0.6*** 0.3 0.4*** 0.2
Beds 94.2*** 51.0 248.5*** 124.5
Overall CMS rating (US n=70) 3.4* 1.3 3.9* 1.2
Health Deficiencies 5.9*** 4.7 3.1*** 3.5
Substandard QOC Deficiencies 0.0 0.26 0.0 0.23
QOC Deficiencies 1.4** 1.5 0.7** 1.1
Fines 0.21** 0.53 0.0** 0.15

Notes:

ŧ

Case Mix Index Adjusted; NGFT= Nasogastric Feeding Tube, SD=standard deviation, CNA=Certified Nursing Assistant, LPN=Licensed Practical Nurse, RN=Registered Nurse; hrs/pt/day=hours per patient per day; CMS=US Centers for Medicare and Medicaid Services; QOC=Quality of Care

*

t-test significance <.05

**

t-test significance <.01

***

t-test significance <.001

Two logistic regression models were developed to compare NGFT acceptance in NYC and nationwide. In the naïve model, SNFs in NYC were 86% less likely to accept patients with NGFT than nationwide SNFs (OR=0.137, p<0.0001, 95% CI= 0.066, 0.275). When controlling for SNF characteristics, including case-mix adjusted staffing hours, type of ownership, number of beds, CMS rating, and recorded health deficiencies, SNFs in NYC were 89% less likely to accept patients with NGFT than nationwide SNFs (B=−2.198(0.60), p<0.001, Model χ2 = 50.1, p<0.001, OR=0.111, 95% CI= 0.032, 0.344). Results of the logistic regression with CMS characteristic covariates are shown in Table 2.

Table 2.

Logistic Regression Representing Relationship between New York City (NYC) Location and Nasogastric Feeding Tube (NGFT) Acceptance Controlling for CMS-Reported Characteristics

B SE 95% CI for odds ratio
Nursing Home Characteristic Lower OR Upper
Intercept −1.019 1.521 0.019 0.361 7.611
NYC location −2.198 0.603 0.032 0.111 0.344
CNA hrs/pt/day* 0.289 0.429 0.578 1.335 3.143
LPN hrs/pt/day* −0.663 0.633 0.141 0.515 1.731
RN hrs/pt/day* 0.128 1.030 0.145 1.137 8.544
Ownership Type
For profit - Corporation Reference value
For profit - Individual 0.125 0.798 0.205 1.133 5.107
For profit - Limited Liability 1.510 1.515 0.157 4.526 131.353
For profit - Partnership 1.169 0.714 0.766 3.219 13.190
Government - City −0.681 2.053 0.007 0.506 27.634
Government - City/County −15.150 2400 NA NA NA
Government - County −0.232 1.199 0.074 0.793 9.552
Government - Federal −15.610 2400 NA NA NA
Government - State −15.970 2400 NA NA NA
Non profit - Church related 0.474 0.942 0.248 1.607 10.505
Non profit - Corporation −0.670 0.553 0.167 0.512 1.486
Non-profit- other −14.950 2400 NA NA NA
Beds 0.000 0.002 0.995 1.000 1.004
Overall CMS rating 0.287 0.222 0.871 1.332 2.090
Health Deficiencies 0.015 0.081 0.865 1.015 1.191
Substandard QOC Deficiencies 1.731 1.098 0.799 5.646 129.448
QOC Deficiencies 0.187 0.218 0.785 1.206 1.857
Fines 0.913 0.655 0.769 2.493 10.712

Note: B=regression beta value, SE= standard error, CI=confidence interval; R2 = 0.234 (Hosmer and Lemeshow), 0.265 (Cox and Snell), 0.362 (Nagelkerke). Model χ2 = 50.1, p<0.001. p<0.001.

*

Case-Mix Index Adjusted, CNA=Certified Nursing Assistant, LPN=Licensed Practical Nurse, RN=Registered Nurse, hrs/pt/day=hours per patient per day; CMS=US Centers for Medicare and Medicaid Services, QOC=Quality of Care

Of the 115 total SNFs indicating NGFT refusal, 86 (USA n=17, NYC n=69) provided more detailed explanations for their policy. Reasons for refusal were coded with 15 descriptive codes that were then categorized into five themes: Safety, SNF capacity, policy, perception of appropriate level of care, and patient quality of life. There were notable differences between NYC SNFs and nationwide SNFs, particularly relating to concern for aspiration risk, which 44% (n=30) of NYC SNF administrators cited as a reason for NGFT non-acceptance, compared to 6% (n=1) of nationwide SNF administrators. NYC SNF administrators also cited facility (23%, n=16) or governmental (9%, n=6) policy as well as safety concerns (23%, n=16) more frequently than nationwide SNF administrators. A detailed comparison of the reasons provided by each group, along with exemplar quotes, is presented in Table 3.

Table 3.

Reasons Provided for Nasogastric Feeding Tube (NGFT) Non-Acceptance by New York City (NYC) and United States (US) Skilled Nursing Facilities (SNFs)

US (n=17) NYC (n=69)
Reason Frequency Exemplar quote Frequency Exemplar quote

Safety
Aspiration risk 1 (6%) “[We have] concerns about risk of aspiration” 30 (44%) “[I've] dealt with too many tubes where the patients have pulled them and they get aspiration pneumonia”
Dislodgement 1 (6%) “[We don't accept NGFT] because of complications like dislodgement” 7 (10%) “...If there were a way to secure the tube.”
Hospital readmission 0 4 (6%) “No [NGFT] because we don't want to have to send the patient back to the hospital if something goes wrong”
Safety 3 (18%) “We don't accept [NFGTs] because of safety concerns” 16 (23%) “Most patients are geriatric so they get confused and don't know how to handle NGT very well so this is a safety concern”
Liability 1 (6%) “[NGFTs are a] liability” 1 (2%) “When they have the tubes, it increases chances for errors and it's a liability issue...”

SNF capacity
Lack of equipment 5 (29%) “[We have] no way of checking placement” 0
Staffing 4 (24%) “[We have] no 24 hour RNs on staff” 4 (6%) “We have licensed practical nurses and only one RN in the building”
Training 0 6 (9%) “[I don't] remember the last time I had to deal with a NG tube and nurses are no longer versed in it.”
Overwhelm 0 1 (2%) “We just don't do it because we cannot handle it; if we had to do NG tubes, we would do them, I have no concerns, but we cannot handle it at the moment”

Policy
Facility policy 1 (6%) “[We] do not accept patients in transitional care with NG tubes” 16 (23%) “The medical director does not want to accept NG tubes”
Government policy 0 6 (9%) “There are regulations from the department of health and [we] have to track how long [the patient has] had it and the willingness to get them onto a G tube”
Corporate policy 1 (6%) “Orders from corporate” 0
Perception of Appropriate Level of Care
Type of facility 1 (6%) “[NGFTs] would have to be a swing bed or an outpatient situation” 1 (2%) “[NGFTs are for] short term care only and nursing homes take long term care”
SOC in other SNFs 0 4 (6%) “Most nursing homes do not take NGT at all”
Patient Quality of Life
Patient QOL 0 3 (4%) “[It is our] policy to not take patients with NG tubes because it is uncomfortable for the patient...”

Note: SOC=standard of care, QOL=quality of life

Discussion

In this study, we demonstrated a significantly lower rate of NGFT acceptance among NYC SNFs compared to a random sample of nationwide SNFs. Notably, when we controlled for staffing hours as well as other SNF characteristics, the likelihood that NGFT acceptance was related to location increased, indicating that staffing, case-mix, facility size, and other SNF characteristics did not explain why NYC SNFs were less likely to accept NGFT. Commonly reported reasons for SNF non-acceptance of patients receiving NGFT feeding among our sample included those related to patient safety and quality of life, policy, and SNF capacity.

Although regional differences in preferential admission for different types of EN have not previously been studied, SNFs in urban locations have been demonstrated to be more likely to use feeding tubes in nursing home residents with advanced cognitive impairment3. Regional variation in feeding tube practices has been reported38,41 and New York has been identified as a region in which the odds of receiving tube feeding are highest37. This study is the first to use qualitative data to explore SNF administrators’ motivations for refusing patients with NGFT. In addition we provide additional detail to differences in regional EN practices, specifically, that while rates of EN are higher, NGFT use is not.

In the current study, interviewees specifically cited aspiration, aspiration pneumonia, dislodgement, and liability as safety reasons for admission policies prohibiting NGFT feeding. However, while the presence of enteral nutrition of any kind is an independent risk factor for pneumonia in observational studies1,42, a causal relationship between feeding route and pneumonia or mortality has not been found20. That one interviewee lamented that NGFT would be more acceptable “if there were a way to secure the tube” is consistent with previous assertions that nasal bridles are underused 22, despite the fact that they have been demonstrated to be a safe and effective way to reduce dislodgment and ensure adequate feeding22-24. Our finding that SNF administrators were concerned about liability is consistent with a vignette-based survey study of primary care physicians (PCPs) in Hawaii in which PCPs who indicated that they would start tube feeding in fictional patients with dementia were also significantly more likely to place great importance on liability concerns as their motivation for doing so43.

Staffing, including RN, LPN, and CNA hours per patient per day, did not explain the difference in NGFT acceptance in our regression models. This is contrary to suggestions that human resource limitations contribute to EN practices in SNFs26. However, among our participants, a larger percentage of SNF administrators in the nationwide sample reported staffing as a motivation to refuse patients receiving NGFT feeding. This suggests that further examination of SNF staff capacity and efficacy in caring for patients with NGFT is necessary and important.

Although several SNF administrators in our cohort indicated that state policy precluded NGFT altogether, or limiting their use to short time periods such as one week or less, this is inconsistent with New York State Department of Health policy, which allows for NGFT to be used for up to 96 days before requiring only that a FG be considered44. EN practice guidelines are published by professional organizations, and indicate that NGFT are a well-accepted option for patients requiring EN, especially for shorter-term use, while FGs are deemed reasonable, but not required, for patients in whom a need for enteral nutrition of more than 30 days is anticipated7.

Other pressures, perceived or actual, might account for SNF feeding tube policies. SNFs are monitored closely by regulators for patient weight loss and other signs of malnutrition37. This may drive an overemphasis on feeding, and could result in unnecessary invasive procedures for feeding access. This is particularly concerning in the patients who have poor prognoses for response to nutrition support, such as those with advanced dementia45. For example, in our experience patients with dysphagic strokes are undergoing FG insertion 2-4 days after the stroke solely to allow rapid discharge to a SNF for subacute rehabilitation, only to be independent of tube feeding in 1-3 weeks.

Future research should focus on identifying what educational, technical, or policy interventions would support NYC SNFs to be more responsive to patient wishes and medical indications in their care of patients requiring nutrition support and allow more inclusive admission policies related to EN. Additional research that clarifies what informs patient perceptions about EN and how information about EN should be communicated by clinicians to patients would further improve care during transitions from hospital to SNFs.

Despite a well-powered sample size and high response rate, the possibility remains that we were unable to control for all of the characteristics that differed between our NYC and nationwide samples. Additionally, in order to reduce participant burden and achieve adequate sample size for our quantitative questions, the qualitative data may lack the context that a more in-depth interview study would capture. Further, because of the limitations of publicly available data, we were unable to explicitly examine the presence of potential differences between rural and urban locales nor differences depending on race and/or ethnicity, both of which have been previously identified as influences on SNF feeding practices36. It is unclear from our data if either of these factors played a role in our findings, but the suggestion of the existence of disparities in care along socioeconomic and/or racial lines should be further investigated. Nevertheless, our study calls into question regional practices relating to the refusal of patients receiving NGFT feeding, and also points toward FGs, which are surgical procedures, being performed for non-medical reasons.

Conclusion

NYC SNFs were significantly less likely to accept patients receiving NGFT feeding when compared to a random sample of US SNFs, even when staffing, case-mix, facility size, and other SNF characteristics were considered. Many SNF administrators cited safety and policy as factors guiding their institutional policies and practices, despite the lack of either evidence linking NGFT feeding to adverse outcomes or definitive governmental policy or practice guidelines related to NGFT feeding. This suggests major gaps in EN research, practice, and policy and has implications for disparity in quality of care, length of hospital stay, cost of care, and patient morbidity and mortality.

Acknowledgments

The authors would like to acknowledge Elizabeth Tipton, PhD, Teachers College, Columbia University, for her invaluable advice regarding the statistics used in this study. She received no compensation. Written permission was received from Dr. Tipton for her inclusion in the acknowledgements.

Dr. Burgermaster is supported by a T32 training grant from the NHLBI (HL007343). Dr. Seres is a consultant/medical director for Community Surgical Services.

References

  • 1.Dorner B, Posthauer ME, Friedrich EK, Robinson GE. Enteral nutrition for older adults in nursing facilities. Nutr Clin Pract. 2011;26(3):261–272. doi: 10.1177/0884533611405794. [DOI] [PubMed] [Google Scholar]
  • 2.Teno JM, Mor V, DeSilva D, Kabumoto G, Roy J, Wetle T. Use of feeding tubes in nursing home residents with severe cognitive impairment. JAMA. 2002;287(24):3211–3212. doi: 10.1001/jama.287.24.3211. [DOI] [PubMed] [Google Scholar]
  • 3.Mitchell SL, Teno JM, Roy J, Kabumoto G, Mor V. Clinical and organizational factors associated with feeding tube use among nursing home residents with advanced cognitive impairment. JAMA. 2003;290(1):73–80. doi: 10.1001/jama.290.1.73. [DOI] [PubMed] [Google Scholar]
  • 4.Arinzon Z, Peisakh A, Berner YN. Evaluation of the benefits of enteral nutrition in long- term care elderly patients. J Am Med Dir Assoc. 2008;9(9):657–662. doi: 10.1016/j.jamda.2008.06.002. [DOI] [PubMed] [Google Scholar]
  • 5.Casarett D, Kapo J, Caplan A. Appropriate use of artificial nutrition and hydration-- fundamental principles and recommendations. N Engl J Med. 2005;353(24):2607–2612. doi: 10.1056/NEJMsb052907. [DOI] [PubMed] [Google Scholar]
  • 6.Angus F, Burakoff R. The percutaneous endoscopic gastrostomy tube. medical and ethical issues in placement. Am J Gastroenterol. 2003;98(2):272–277. doi: 10.1111/j.1572-0241.2003.07267.x. [DOI] [PubMed] [Google Scholar]
  • 7.Bankhead R, Boullata J, Brantley S, et al. Enteral nutrition practice recommendations. JPEN J Parenter Enteral Nutr. 2009;33(2):122–167. doi: 10.1177/0148607108330314. [DOI] [PubMed] [Google Scholar]
  • 8.Kuo S, Rhodes RL, Mitchell SL, Mor V, Teno JM. Natural history of feeding-tube use in nursing home residents with advanced dementia. J Am Med Dir Assoc. 2009;10(4):264–270. doi: 10.1016/j.jamda.2008.10.010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Smoliner C, Volkert D, Wittrich A, Sieber CC, Wirth R. Basic geriatric assessment does not predict in-hospital mortality after PEG placement. BMC Geriatr. 2012;12(52) doi: 10.1186/1471-2318-12-52. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.DiMaria-Ghalili RA, Bankhead R, Fisher AA, Kovacevich D, Resler R, Guenter PA. Standards of practice for nutrition support nurses. Nutrition in Clinical Practice. 2007;22(4):458–465. doi: 10.1177/0115426507022004458. [DOI] [PubMed] [Google Scholar]
  • 11.Goldberg LS, Altman KW. The role of gastrostomy tube placement in advanced dementia with dysphagia: a critical review. Clin Interv Aging. 2014;9:1733–1739. doi: 10.2147/CIA.S53153. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Finucane TE, Christmas C, Travis K. Tube feeding in patients with advanced dementia: a review of the evidence. JAMA. 1999;282(14):1365–1370. doi: 10.1001/jama.282.14.1365. [DOI] [PubMed] [Google Scholar]
  • 13.Baltz JG, Argo CK, Al-Osaimi AM, Northup PG. Mortality after percutaneous endoscopic gastrostomy in patients with cirrhosis: a case series. Gastrointest Endosc. 2010;72(5):1072–1075. doi: 10.1016/j.gie.2010.06.043. [DOI] [PubMed] [Google Scholar]
  • 14.Keung EZ, Liu X, Nuzhad A, Rabinowits G, Patel V. In-hospital and long-term outcomes after percutaneous endoscopic gastrostomy in patients with malignancy. J Am Coll Surg. 2012;215(6):777–786. doi: 10.1016/j.jamcollsurg.2012.08.013. [DOI] [PubMed] [Google Scholar]
  • 15.Niv Y, Abuksis G. Indications for percutaneous endoscopic gastrostomy insertion: ethical aspects. Dig Dis. 2002;20(3-4):253–256. doi: 10.1159/000067676. [DOI] [PubMed] [Google Scholar]
  • 16.Schrag SP, Sharma R, Jaik NP, et al. Complications related to percutaneous endoscopic gastrostomy (PEG) tubes. A comprehensive clinical review. J Gastrointestin Liver Dis. 2007;16(4):407–418. [PubMed] [Google Scholar]
  • 17.Lee C, Im JP, Kim JW, et al. Risk factors for complications and mortality of percutaneous endoscopic gastrostomy: a multicenter, retrospective study. Surg Endosc. 2013;27(10):3806–3815. doi: 10.1007/s00464-013-2979-3. [DOI] [PubMed] [Google Scholar]
  • 18.Rahnemai-Azar AA, Rahnemaiazar AA, Naghshizadian R, Kurtz A, Farkas DT. Percutaneous endoscopic gastrostomy: indications, technique, complications and management. World J Gastroenterol. 2014;20(24):7739–7751. doi: 10.3748/wjg.v20.i24.7739. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Arora G, Rockey D, Gupta S. High In-hospital mortality after percutaneous endoscopic gastrostomy: results of a nationwide population-based study. Clin Gastroenterol Hepatol. 2013;11(11):1437–1444. e1433. doi: 10.1016/j.cgh.2013.04.011. [DOI] [PubMed] [Google Scholar]
  • 20.Gomes CA, Jr., Andriolo RB, Bennett C, Lustosa SA. Percutaneous endoscopic gastrostomy versus nasogastric feeding tubes for adults with swallowing disturbances. The Cochrane Library. 2015 doi: 10.1002/14651858.CD008096.pub4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Jaafar MH, Mahadeva S, Morgan K, Tan MP. Percutaneous endoscopic gastrostomy versus nasogastric feeding in older individuals with non-stroke dysphagia: a systematic review. J Nutr Health Aging. 2015;19(2):190–197. doi: 10.1007/s12603-014-0527-z. [DOI] [PubMed] [Google Scholar]
  • 22.Seder CW, Stockdale W, Hale L, Janczyk RJ. Nasal bridling decreases feeding tube dislodgment and may increase caloric intake in the surgical intensive care unit: a randomized, controlled trial. Crit Care Med. 2010;38(3):797–801. doi: 10.1097/CCM.0b013e3181c311f8. [DOI] [PubMed] [Google Scholar]
  • 23.Webb G, Gupta P, Fitchett J, Simmons J, De Silva A. Efficacy of nasal bridles in avoiding percutaneous endoscopic gastrostomy placement. Frontline Gastroenterology. 2012;3(2):109–111. doi: 10.1136/flgastro-2012-100110. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Seder CW, Janczyk R. The routine bridling of nasojejunal tubes is a safe and effective method of reducing dislodgement in the intensive care unit. Nutr Clin Pract. 2008;23(6):651–654. doi: 10.1177/0884533608326139. [DOI] [PubMed] [Google Scholar]
  • 25.Wilcox CM, McClave SA. To PEG or not to PEG. Clin Gastroenterol Hepatol. 2013;11(11):1451–1452. doi: 10.1016/j.cgh.2013.07.009. [DOI] [PubMed] [Google Scholar]
  • 26.Breier-Mackie SJ. PEGs and ethics revisited: a timely reflection in the wake of the Terri Schiavo case. Gastroenterol Nurs. 2005;28(4):292–297. doi: 10.1097/00001610-200507000-00003. [DOI] [PubMed] [Google Scholar]
  • 27.Rabeneck L, McCullough LB, Wray NP. Ethically justified, clinically comprehensive guidelines for percutaneous endoscopic gastrostomy tube placement. Lancet. 1997;349(9050):496–498. doi: 10.1016/S0140-6736(96)07369-2. [DOI] [PubMed] [Google Scholar]
  • 28.Janes SE, Price CS, Khan S. Percutaneous endoscopic gastrostomy: 30-day mortality trends and risk factors. J Postgrad Med. 2005;51(1):23–28. discussion 28-29. [PubMed] [Google Scholar]
  • 29.Oppong P, Pitts N, Chudleigh V, et al. Pain and Anxiety Experienced by Patients Following Placement of a Percutaneous Endoscopic Gastrostomy. JPEN J Parenter Enteral Nutr. 2014 doi: 10.1177/0148607114551798. [DOI] [PubMed] [Google Scholar]
  • 30.Blumenstein I, Shastri YM, Stein J. Gastroenteric tube feeding: techniques, problems and solutions. World J Gastroenterol. 2014;20(26):8505–8524. doi: 10.3748/wjg.v20.i26.8505. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Leeds JS, McAlindon ME, Grant J, Robson HE, Lee FK, Sanders DS. Survival analysis after gastrostomy: a single-centre, observational study comparing radiological and endoscopic insertion. Eur J Gastroenterol Hepatol. 2010;22(5):591–596. doi: 10.1097/MEG.0b013e328332d2dd. [DOI] [PubMed] [Google Scholar]
  • 32.Johnston SD, Tham TC, Mason M. Death after PEG: results of the National Confidential Enquiry into Patient Outcome and Death. Gastrointest Endosc. 2008;68(2):223–227. doi: 10.1016/j.gie.2007.10.019. [DOI] [PubMed] [Google Scholar]
  • 33.Yarmus L, Gilbert C, Lechtzin N, Imad M, Ernst A, Feller-Kopman D. Safety and feasibility of interventional pulmonologists performing bedside percutaneous endoscopic gastrostomy tube placement. Chest. 2013;144(2):436–440. doi: 10.1378/chest.12-2550. [DOI] [PubMed] [Google Scholar]
  • 34.Abuksis G, Mor M, Plaut S, Fraser G, Niv Y. Outcome of percutaneous endoscopic gastrostomy (PEG): comparison of two policies in a 4-year experience. Clin Nutr. 2004;23(3):341–346. doi: 10.1016/j.clnu.2003.08.001. [DOI] [PubMed] [Google Scholar]
  • 35.Boll J, Daly S, Smolevitz J, et al. Safety and efficacy of outpatient percutaneous endoscopic gastrostomy for patients with head and neck cancer. Am Surg. 2015;81(2):216–219. [PubMed] [Google Scholar]
  • 36.Mitchell SL, Kiely DK, Gillick MR. Nursing home characteristics associated with tube feeding in advanced cognitive impairment. J Am Geriatr Soc. 2003;51(1):75–79. [PubMed] [Google Scholar]
  • 37.Ahronheim JC, Mulvihill M, Sieger C, Park P, Fries BE. State practice variations in the use of tube feeding for nursing home residents with severe cognitive impairment. J Am Geriatr Soc. 2001;49(2):148–152. doi: 10.1046/j.1532-5415.2001.49035.x. [DOI] [PubMed] [Google Scholar]
  • 38.Teno JM, Mitchell SL, Skinner J, et al. Churning: the association between health care transitions and feeding tube insertion for nursing home residents with advanced cognitive impairment. J Palliat Med. 2009;12(4):359–362. doi: 10.1089/jpm.2008.0168. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Creswell JW, Plano Clark VL. Designing and conducting mixed methods research. 2nd ed. SAGE Publications; Los Angeles: 2011. [Google Scholar]
  • 40.[CMS]. CfMaMS. [November 15, 2013];Nursing Home Compare. https://data.medicare.gov/data/nursing-home-compare.
  • 41.Teno JM, Mitchell SL, Gozalo PL, et al. Hospital characteristics associated with feeding tube placement in nursing home residents with advanced cognitive impairment. JAMA. 2010;303(6):544–550. doi: 10.1001/jama.2010.79. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Tejada Artigas A, Bello Dronda S, Chacon Valles E, et al. Risk factors for nosocomial pneumonia in critically ill trauma patients. Crit Care Med. 2001;29(2):304–309. doi: 10.1097/00003246-200102000-00015. [DOI] [PubMed] [Google Scholar]
  • 43.Bell C, Somogyi-Zalud E, Masaki K, Fortaleza-Dawson T, Blanchette PL. Factors associated with physician decision-making in starting tube feeding. J Palliat Med. 2008;11(6):915–924. doi: 10.1089/jpm.2007.0289. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.New York State Department of Health Policy. :415.12. [Google Scholar]
  • 45.Murphy LM, Lipman TO. Percutaneous endoscopic gastrostomy does not prolong survival in patients with dementia. Arch Intern Med. 2003;163(11):1351–1353. doi: 10.1001/archinte.163.11.1351. [DOI] [PubMed] [Google Scholar]

RESOURCES